APA (7th ed.) Citation

Heidrich, K., & Krämer, A. (2017). Allogeneic hematopoietic cell transplantation in intermediate risk acute myeloid leukemia negative for FLT3-ITD, NPM1- or biallelic CEBPA mutations. Annals of oncology, 28(11), . https://doi.org/10.1093/annonc/mdx500

Chicago Style (17th ed.) Citation

Heidrich, Katharina, and Alwin Krämer. "Allogeneic Hematopoietic Cell Transplantation in Intermediate Risk Acute Myeloid Leukemia Negative for FLT3-ITD, NPM1- or Biallelic CEBPA Mutations." Annals of Oncology 28, no. 11 (2017). https://doi.org/10.1093/annonc/mdx500.

MLA (9th ed.) Citation

Heidrich, Katharina, and Alwin Krämer. "Allogeneic Hematopoietic Cell Transplantation in Intermediate Risk Acute Myeloid Leukemia Negative for FLT3-ITD, NPM1- or Biallelic CEBPA Mutations." Annals of Oncology, vol. 28, no. 11, 2017, https://doi.org/10.1093/annonc/mdx500.